Aevi Genomic Medicine

About:

Aevi Genomic Medicine focuses on translating genetic discoveries into novel therapies.

Website: http://aevigenomics.com/

Top Investors: Alta Partners, The Children's Hospital of Philadelphia, Alta Berkeley Venture Partners, Koor Corporate Venture Capital

Description:

Aevi Genomic Medicine focuses on translating genetic discoveries into novel therapies. It is dedicated to unlocking the potential of genomic medicine to translate genetic discoveries into novel therapies. Driven by a commitment to patients with pediatric onset life-altering diseases, the company's research and development efforts leverage an internal genomics platform and an ongoing collaboration with the Center for Applied Genomics at The Children's Hospital of Philadelphia.

Total Funding Amount:

$78.5M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Wayne, Pennsylvania, United States

Founded Date:

2000-01-01

Contact Email:

Mary.Scavello(AT)aevigenomics.com

Founders:

Andrew Pearlman

Number of Employees:

11-50

Last Funding Date:

2018-08-21

IPO Status:

Public

Industries:

© 2025 bioDAO.ai